Sienna Biopharmaceuticals SEC Filings https://investors.siennabio.com/ Sienna Biopharmaceuticals SEC Filings en DEFA14A: Additional proxy soliciting materials - definitive https://investors.siennabio.com/sec-filings/sec-filing/defa14a/0001193125-19-103356 Sienna Biopharmaceuticals, Inc. Thu, 11 Apr 2019 08:10:38 -0400 Sienna Biopharmaceuticals SEC Filings 7526 DEF 14A: Official notification to shareholders of matters to be brought to a vote ("Proxy") https://investors.siennabio.com/sec-filings/sec-filing/def-14a/0001193125-19-103352 Sienna Biopharmaceuticals, Inc. Thu, 11 Apr 2019 08:04:38 -0400 Sienna Biopharmaceuticals SEC Filings 7521 4: Statement of changes in beneficial ownership of securities https://investors.siennabio.com/sec-filings/sec-filing/4/0001562180-19-002196 Sienna Biopharmaceuticals, Inc. Wed, 03 Apr 2019 17:48:11 -0400 Sienna Biopharmaceuticals SEC Filings 7516 3: Initial filing by director officer or owner of more than ten percent. https://investors.siennabio.com/sec-filings/sec-filing/3/0001562180-19-002194 Sienna Biopharmaceuticals, Inc. Wed, 03 Apr 2019 17:28:11 -0400 Sienna Biopharmaceuticals SEC Filings 7511 8-K: Report of unscheduled material events or corporate event https://investors.siennabio.com/sec-filings/sec-filing/8-k/0001193125-19-082171 Sienna Biopharmaceuticals, Inc. Thu, 21 Mar 2019 16:15:57 -0400 Sienna Biopharmaceuticals SEC Filings 7506 S-8: Securities offered to employees pursuant to employee benefit plans https://investors.siennabio.com/sec-filings/sec-filing/s-8/0001193125-19-074168 Sienna Biopharmaceuticals, Inc. Thu, 14 Mar 2019 09:22:41 -0400 Sienna Biopharmaceuticals SEC Filings 7496 10-K: Annual report which provides a comprehensive overview of the company for the past year https://investors.siennabio.com/sec-filings/sec-filing/10-k/0001193125-19-074162 Sienna Biopharmaceuticals, Inc. Thu, 14 Mar 2019 09:20:42 -0400 Sienna Biopharmaceuticals SEC Filings 7491 8-K: Report of unscheduled material events or corporate event https://investors.siennabio.com/sec-filings/sec-filing/8-k/0001193125-19-074151 Sienna Biopharmaceuticals, Inc. Thu, 14 Mar 2019 09:14:41 -0400 Sienna Biopharmaceuticals SEC Filings 7486 SC 13D: Filing by person(s) reporting owned shares of common stock in a public company >5% https://investors.siennabio.com/sec-filings/sec-filing/sc-13d/0001072613-19-000121 Sienna Biopharmaceuticals, Inc. Wed, 06 Mar 2019 16:43:47 -0500 Sienna Biopharmaceuticals SEC Filings 7466 4: Statement of changes in beneficial ownership of securities https://investors.siennabio.com/sec-filings/sec-filing/4/0001012975-19-000199 Sienna Biopharmaceuticals, Inc. Tue, 26 Feb 2019 21:13:56 -0500 Sienna Biopharmaceuticals SEC Filings 7456